Quick Answer
Xenetic Biosciences, Inc. reported Total Assets of $8.36 million for fiscal year 2025.
Xenetic Biosciences, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $8.36M | +21.2% |
| 2024 | $6.90M | -34.9% |
| 2023 | $10.61M | -28.0% |
| 2022 | $14.72M | -25.7% |
| 2021 | $19.82M | +50.3% |
| 2020 | $13.18M | -38.8% |
| 2019 | $21.55M | +49.3% |
| 2018 | $14.43M | -24.7% |
| 2017 | $19.16M | -8.6% |
| 2016 | $20.97M | +24.0% |
| 2015 | $16.91M | +3.6% |
| 2014 | $16.32M | -16.2% |
| 2013 | $19.47M | +3898.6% |
| 2013 | $486.8K | +50.2% |
| 2012 | $324.1K | +45.7% |
| 2011 | $222.5K | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $5.07M | -37.0% | -5.3% |
| June 30, 2025 | $5.35M | -40.7% | -7.6% |
| March 31, 2025 | $5.79M | -38.4% | -16.1% |
| December 31, 2024 | $6.90M | -34.9% | -14.2% |
| September 30, 2024 | $8.05M | -32.7% | -10.9% |
| June 30, 2024 | $9.03M | -29.1% | -3.8% |
| March 31, 2024 | $9.39M | -31.5% | -11.4% |
| December 31, 2023 | $10.61M | -28.0% | -11.3% |
- Xenetic Biosciences, Inc. showed an increase of +21.2% in Total Assets compared to the prior fiscal year.
- Over the 2011–2025 period, Xenetic Biosciences, Inc.’s total assets has grown by 3659.0% (from $222.5 thousand to $8.36 million).
- The most recent figure is from Xenetic Biosciences, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: